NASDAQ
CinCor Pharma, Inc. (CINC) has a free cash flow growth of 22.38% as of Friday, May 29, 2026. This represents a 170.12% increase compared to its 12-month average of -31.92%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.